The origin of CD95-gene mutations in B-cell lymphoma (Q34584971)

3 August 2017

1 reference

title

The origin of CD95-gene mutations in B-cell lymphoma (English)

1 reference

3 August 2017

4

Ralf Küppers

0 references

Markus Müschen

series ordinal

1

object named as

Markus Müschen

0 references

Klaus Rajewsky

object named as

Klaus Rajewsky

series ordinal

2

0 references

Martin Krönke

series ordinal

3

object named as

Martin Krönke

1 reference

3 August 2017

Markus Müschen

1

1 reference

3 August 2017

publication date

1 February 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

23

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

75-80

1 reference

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Death-receptor contribution to the germinal-center reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Defining CD95 as a tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

CD95 ligand expression as a mechanism of immune escape in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon gamma and all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Somatic hypermutation in normal and transformed human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Somatic hypermutation of immunoglobulin genes is linked to transcription initiation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Cellular origin of human B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Death pathway genes Fas (Apo-1/CD95) and Bik (Nbk) show no mutations in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Analysis of Fas/CD95 gene somatic mutations in ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

CD95 ligand expression in dedifferentiated breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Fas gene mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Rare occurrence of classical Hodgkin's disease as a T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902115-9

7 January 2021

10.1016/S1471-4906(01)02115-9

Identifiers

DOI

1 reference

3 August 2017

1 reference